Citadel Advisors »

Neuropace shares owned by Citadel Advisors

Quarter-by-quarter ownership of Neuropace (NPCE) shares owned by Citadel Advisors from 13F filings

Historical chart of Citadel Advisors investment in Neuropace

Tip: Access up to 7 years of quarterly data

All positions including Neuropace held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Neuropace by Citadel Advisors

Quarter filed Position value Share count Share price at filing
2023-12-31 $248k 24k 10.31
2022-06-30 $109k 22k 5.01
2021-12-31 $101k 10k 10.09
2021-09-30 $411k 26k 15.91

More positions owned by Citadel Advisors

Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Tesla Motors Call Option (TSLA)
NVIDIA Corporation Call Option (NVDA)
Ishares Tr Russell 2000 Etf Call Option (IWM)
Microsoft Corporation Call Option (MSFT)
Meta Platforms Cl A Call Option (META)
Apple Call Option (AAPL)
Amazon Call Option (AMZN)
Ishares Tr Iboxx Hi Yd Etf Call Option (HYG)
Alphabet Cap Stk Cl A Call Option (GOOGL)
Advanced Micro Devices Call Option (AMD)
Netflix Call Option (NFLX)
Alphabet Cap Stk Cl C Call Option (GOOG)
Booking Holdings Call Option (BKNG)

View all positions for Citadel Advisors

Top funds holding Neuropace

OrbiMed Advisors
Soleus Capital Management
Nantahala Capital Management
Kent Lake Capital
Vanguard Group
Millennium Management
Jane Street
Citigroup
Bank of America Corporation
Balyasny Asset Management
683 Capital Management
Citadel Advisors
Laurion Capital Management
Man Group
Townsquare Capital

View all funds holding Neuropace